Navigation Links
Boehringer Ingelheim to Sponsor the Bonnie J. Addario Lung Cancer Foundation's Efforts to Promote Genetic Biomarker Testing
Date:11/7/2013

SAN CARLOS, Calif. and RIDGEFIELD, Conn., Nov. 7, 2013 /PRNewswire/ -- The Bonnie J. Addario Lung Cancer Foundation (ALCF) and Boehringer Ingelheim Pharmaceuticals, Inc. (BI) today announced that BI will sponsor ALCF's efforts to raise awareness about the importance of immediate genetic biomarker testing for patients with advanced non-small cell lung cancer (NSCLC).

"This sponsorship is important because of how critical genetic biomarker testing is for an accurate diagnosis and for helping to match each patient with the most appropriate therapy as early as possible," said Bonnie J. Addario, founder of the ALCF and a stage 3B lung cancer survivor. "This testing sets the stage for a new personalized standard of care with the goal of improving outcomes for patients with advanced non-small cell lung cancer."

ALCF will honor BI at its Annual Gala in San Francisco on November 9 with the prestigious "Simply the Best" award recognizing BI's contributions to the lung cancer community. Specifically, BI has for nearly two years led an initiative called Let's Test to increase awareness of biomarker testing in advanced NSCLC. Let's Test provides relevant information and educational resources to healthcare providers with the goal of helping to improve patient outcomes. The initiative also outlines how the diagnosis and treatment of advanced NSCLC has evolved, as well as the multidisciplinary team of healthcare providers that are involved in the process.

"Boehringer Ingelheim is honored to be supporting the Bonnie J. Addario Lung Cancer Foundation to help communicate the importance of immediate biomarker testing for patients diagnosed with advanced non-small cell lung cancer," said Kevin Lokay, vice president and business unit head, Oncology, Boehringer Ingelhei
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.; Bonnie J. Addario Lung Cancer Foundation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
2. New Boehringer Ingelheim Oncology Data to be Presented at ESMO 2012 Congress
3. Oxford BioTherapeutics and Boehringer Ingelheim Enter Collaboration to Discover Novel Antibody Targets in Cancer
4. Boehringer Laboratories LLC Awarded HPG Contract for Clinical Suction Regulators
5. Ventana to collaborate with Boehringer Ingelheim on the development of companion diagnostic tests
6. Aviir Diagnostics Laboratory in Collaboration with Cause;ology Sponsors "Storyland," a Red Carpet Charity Extravaganza in Hollywood
7. Cambridge Healthtech Associates™ Co-Sponsors BIO Debrief Networking Reception with Xconomy
8. APCER Pharma Sponsors Major Industry Conference
9. Janssen Research & Development, LLC, Sponsors First of its Kind Research Initiative to Advance Multiple Sclerosis Science
10. MO BIO Laboratories, Inc. Becomes Exclusive Sponsor Of Natures Human Microbiota Special
11. Pinnaclife To Sponsor The Nebraska Academy of Nutrition and Dietetics Fuel Up With Color 5K And 1 Mile Fun Run
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... SHENZHEN , Kina, 22. juli ... (BGI Tech), et datterselskab af BGI, verdens største ... human whole exome-sekvenseringstjeneste baseret på Complete Genomics brancheførende ... i branchen for at levere patenterede sekvenseringsteknologier med ... typer varianter, blev købt af BGI i 2013. ...
(Date:7/22/2014)... -- Hussey Copper , a leader in copper ... announces Pullman Regional Hospital,s conversion of more than 1,100 ... surface, at a nominal cost.  This reasonably priced surface ... bacteria within 2 hours of exposure 1 and will ... diseases in its facilities. Pullman Regional Hospital, ...
(Date:7/22/2014)... WA (PRWEB) July 22, 2014 Quorum Review ... new service for large clinical trials called Quick Step™ ... is designed to address the research industry’s need for seamless ... The service is available for studies planning 50 or more ... a combined planned North American site count of 80 or ...
(Date:7/22/2014)... Lawrence, KS (PRWEB) July 22, 2014 ... as attention-deficit hyperactivity disorder (ADHD) is diagnosed, selecting medication ... trial and error. Analyzing brain patterns by using electroencephalography ... best result and thus lower the risk of adverse ... Electroencephalography Phenotypes and Biomarkers” in the current issue ...
Breaking Biology Technology:BGI Tech lancerer Human Whole Exome-sekvenseringstjeneste på Complete Genomics avancerede platform 2Pullman Regional Hospital changes more than 1,100 touch points to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 2Pullman Regional Hospital changes more than 1,100 touch points to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 3Quorum Review IRB Launches New Quick Step™ Service for Large Clinical Trials 2Quorum Review IRB Launches New Quick Step™ Service for Large Clinical Trials 3Analyzing Brain Patterns with EEG Can Help Predict Effective Use of Medication 2Analyzing Brain Patterns with EEG Can Help Predict Effective Use of Medication 3
... (Nasdaq: CHDX ) a leading independent American provider ... of China,announced that it intends to release its financial ... Thursday, June 12, 2008., Chindex,s management will also ... 9:00 a.m. Eastern Time to discuss its financial results., ...
... Quarter ... Salesforce ... Insulet Corporation,(Nasdaq: PODD ), a leader in wearable insulin ... for,the first quarter ended March 31, 2008., First quarter 2008 ...
... Inc.,(NYSE: HSP ), a global specialty pharmaceutical ... Bowles, CFA, has been elected to,the company,s board ... expertise from leadership positions held at major,multinational consumer ... of Bowles expands Hospira,s board to nine directors, ...
Cached Biology Technology:Chindex International Announces Conference Call to Discuss Its Fiscal 2008 Fourth Quarter and Year End Results on Thursday, June 12, 2008 2Chindex International Announces Conference Call to Discuss Its Fiscal 2008 Fourth Quarter and Year End Results on Thursday, June 12, 2008 3Insulet Reports First Quarter 2008 Results 2Insulet Reports First Quarter 2008 Results 3Insulet Reports First Quarter 2008 Results 4Insulet Reports First Quarter 2008 Results 5Insulet Reports First Quarter 2008 Results 6Insulet Reports First Quarter 2008 Results 7Hospira Expands Board of Directors 2
(Date:7/22/2014)... you,re allergic to dust mites (and chances are you ... at the University of Iowa have developed a vaccine ... body,s immune response. In animal tests, the nano-sized vaccine ... exposure to the allergens, according to the paper, published ... Scientists) Journal . One big reason why it ...
(Date:7/22/2014)... be on the horizon. Bacteria that produce a ... insulin resistance and other adverse effects of a ... discovered., "Of course it,s hard to speculate from ... Ph.D., assistant professor of Pharmacology. "But essentially we,ve ... in mice, even though they,re eating a high-fat ...
(Date:7/22/2014)... The challenges faced by researchers in modifying properties of ... a simple technique, thanks to recent innovative studies conducted ... , Through the use of a simple, efficient and ... NUS research teams, led by Professor Sow Chorng Haur ... of Science, demonstrated that the properties of two different ...
Breaking Biology News(10 mins):Researchers create vaccine for dust-mite allergies 2Vanderbilt study shows therapeutic bacteria prevent obesity in mice 2NUS scientists use low cost technique to improve properties and functions of nanomaterials 2NUS scientists use low cost technique to improve properties and functions of nanomaterials 3
... has shown that enhancing the production of a protein ... neuron death associated with Alzheimer,s, at the expense of ... amyloid-beta protein plaques within the brain is a major ... contribute to disease progression. Normally, special enzymes chew up ...
... peas to show that one copy of a gene (allele) is ... the progeny, the inherited genes are expressed at the right time ... that although gene products could be modified during the life of ... Now it appears that one copy of some genes ...
... ARLINGTON, Va., June 10 Stanley, Inc. (NYSE:,SXE), ... services,to the U.S. federal government, announced today that ... Oberon Associates, Inc. (Oberon), an,engineering, intelligence operations and ... approximately $170 million in cash,subject to certain working ...
Cached Biology News:Genome communication 2Genome communication 3Genome communication 4Stanley to Acquire Oberon Associates 2Stanley to Acquire Oberon Associates 3Stanley to Acquire Oberon Associates 4
... an automated multiplexing platform that uses advanced ... sequence detection and pharmacogenetics applications. Multiple samples ... an open and flexible electronic microarray, the ... all tests sites have been utilized. This ...
The Bio-Plex Manager version 3.0 to 4.0 workstation software upgrade kit is used to upgrade existing Bio-Plex Manager version 3.0 software to version 4.0 security edition software....
... siRNA --- a cocktail of 3 siRNAs ... interestis our most popular product. The siTrio ... knockdown of your target gene when used ... transfection and confirmation of optimal transfection with ...
... D kit is an enzymeimmunoassay intended ... D (25-OH D) and other hydroxylated ... Our patented DIRECT assay technology eliminates ... centrifugation and therefore facilitates automation on ...
Biology Products: